The present disclosure provides pharmaceutical compositions including a cannabinoid acid ester compound alone or in combination with one or more additional cannabinoid compounds. In some embodiments, the cannabinoid acid ester compound is a tetrahydrocannabinolic acid (THCA) ester. In some embodiments, the cannabinoid acid ester compound is a cannabigerolic (CBGA) acid ester. In some embodiments, the cannabinoid acid ester compound is a cannabinolic (CBNA) acid ester. A variety of therapeutic applications in which the cannabinoid acid ester compounds and pharmaceutical compositions find use are also provided, including combination therapies using cannabinoid acid ester compounds and one or more additional therapeutic agents.
本公开提供了包含一种
大麻酸酯化合物的药物组合物,该化合物单独或与一个或多个额外的
大麻化合物结合使用。在某些实施例中,
大麻酸酯化合物是四氢
大麻酸(THCA)酯。在某些实施例中,
大麻酸酯化合物是
大麻二酚酸(CBGA)酯。在某些实施例中,
大麻酸酯化合物是
大麻酚(CBNA)酯。还提供了
大麻酸酯化合物和药物组合物在各种治疗应用中的用途,包括使用
大麻酸酯化合物和一个或多个额外治疗剂的联合疗法。